Clinical Trials Browser

Has results × regorafenib × 30 days × Clear all

NCT04327700 2026-03-05

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib

Phase 2 Terminated

2 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT03828799 2026-02-27

FOLFIRINOX-R

Phase 1/2 Completed

13 enrolled 22 charts

Gastrointestinal

Colorectal Neoplasms